A
FOLD
Amicus Therapeut
14.44
0.000.00%After Hours: 14.47 +0.03 +0.21%16:28 04/02 EDT
OPEN/PREV CLOSE14.43/14.44
TODAY RANGE14.43-14.44
VOL2.99M
MARKET CAP4.53B
52 WEEK RANGE5.51-14.46
AVG VOL (3M)6.27M
% TURNOVER0.95%
TURNOVER--
P/E (TTM)-164.2776
% RANGE0.07%
EPS(TTM)-0.0879
P/E(FORWARD)44.43
P/B16.37
BVPS0.8822
DIVIDEND--
P/S7.08
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP4.38B
SHARES OUTSTANDING314.00M
NEXT EARNINGS04/29-05/04
FREE FLOAT303.40M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·03/11 10:36
BioMarin price target lowered to $85 from $97 at BofA
Reuters·03/03 21:55
Amicus Therapeutics Inc. Held Special Stockholder Meeting
TipRanks·03/03 21:34
Amicus Stockholders Approve BioMarin Acquisition at Special Meeting
Benzinga·03/02 11:10
BioMarin Strengthens PKU Portfolio With FDA Approval For Younger Patients
TipRanks·02/26 13:52
BioMarin price target raised to $104 from $98 at Canaccord
TipRanks·02/25 11:56
BioMarin price target lowered to $86 from $106 at Guggenheim
TipRanks·02/24 12:55
BioMarin price target lowered to $95 from $98 at Oppenheimer
Barchart·02/23 08:38
Amicus Therapeutics: Q4 Earnings Snapshot
NASDAQ·02/23 06:36
Amicus Therapeutics Q4 Revenue Climbs
Reuters·02/20 21:10
Amicus Q4 revenue beats estimates
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.